SCHEMBL4844620

SCHEMBL4844620

COc1ccc2c(c1)/C(=C/C(=O)c1cccc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)c1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TCF4 P15884 1/20 0.47
CTNNB1 P35222 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
HTT P42858 3/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALOX12 P18054 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.44
PLAU P00749 2/20 0.43
PLAT P00750 1/20 0.43
PFKFB4 Q16877 1/20 0.43
GAA P10253 1/20 0.43
THRB P10828 1/20 0.42
CYP19A1 P11511 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844632 1.00 TCF4 (0.47) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4835335 0.93 TCF4 (0.49) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4835345 0.93 TCF4 (0.49) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4844730 0.92 PLAU (0.48) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL4844743 0.92 PLAU (0.48) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL4843842 0.91 TCF4 (0.48) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4843851 0.91 TCF4 (0.48) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4843829 0.91 TCF4 (0.45) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4843837 0.91 TCF4 (0.45) TCF4CTNNB1MEN1KMT2AHTT
SCHEMBL4841971 0.90 MEN1 (0.47) TCF4CTNNB1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 TCF4 2483/4885CTNNB1 2100/4885MEN1 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.